prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |review
The DALY approach which is the basis of the Global Burden of Disease currently in use has been much critisized because the method presupposes that life years of disabled people are worth less than life years of people without disabilities. The method assumes that disabled people are less entitled to scarce health resources for interventions that would extend their lives. The line of thought from the first question to the application in cost effectiveness analyses seems to be that the healthier the person, the more valuable their life is to themself and to society and the greater their claim on restricted healthcare resources to have their life extended. This makes sense only if the value of life is not seen as a dimension distinct from health, but rather as a direct positive function of health.

At worst, this line of thinking could lead to the following table: